Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 407-830-6 | CAS number: 103335-54-2 DELTA-5-AZA-ACID
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Adequacy of study:
- other information
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Directive 84/449/EEC, Annex V, Method B7 and OECD Guideline No. 407
- GLP compliance:
- yes
- Limit test:
- no
Test animals
- Species:
- other: Rat, Sprague Dawley CD
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- other: 1% aqueous methylcellulose
- Details on oral exposure:
- Method of administration:
Gavage - Duration of treatment / exposure:
- Test duration: 28 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 0 mg/kg bw/day
Male: 5 animals at 10 mg/kg bw/day
Male: 5 animals at 150 mg/kg bw/day
Male: 5 animals at 1000 mg/kg bw/day
Female: 5 animals at 0 mg/kg bw/day
Female: 5 animals at 10 mg/kg bw/day
Female: 5 animals at 150 mg/kg bw/day
Female: 5 animals at 1000 mg/kg bw/day
Results and discussion
Results of examinations
- Details on results:
- Clinical observations:
Clinical Signs:
There were no mortalities or clinical signs of reaction
following treatment with the test substance.
Bodyweights:
There were no statistically significant differences between
bodyweight gains of the rats treated with the test substance
and those of controls.
Food Consumption:
Slightly higher food consumption was recorded for male and
female rats receiving the test substance. However, these
increases were slight and not dose dependent.
Water consumption:
Virtual assessment of water consumption during weeks 1, 3
and 4 indicated an increase in water consumption in the high
and intermediate dose groups for male rats and at all
dosage levels for the female rats, confirmed by daily
weighing in week 2.
Water consumption for the low dose group revealed a slight
numerical increase in water consumption for the females only
.
Laboratory findings:
Haematology:
A significant decrease in the number of lymphocytes was seen
in male rats in the high and intermediate dose groups
(P<0.01) in comparison with controls. This was reflected in
a significantly lower total white blood cell count for males
at these dosage levels (P<0.5). A lower haemoglobin
concentration was calculated for female rats in the high and
intermediate dose groups (P<0.05 and P<0.01 respectively)
compared with controls, accompanied by a slightly lower
packed cell volume (P<0.05). Changes were minor in nature
and values were within the expected range for rats of this
age and sex. The differences seen were not considered
attributable to treatment.
Intergroup variation in the remaining parameters measured
revealed no significant differences from controls.
Biochemistry:
Significantly lower sodium ion levels were recorded for
female rats in the high and intermediate dose groups
(P<0.05) in comparison with controls. Male rats in the high
dose groups showed an increase in cholesterol levels
(P<0.05). However, these changes were minor in nature and
within the expected range for rats of this age and strain.
These differences were neither statistically significant nor
dosage dependent. Intergroup variation among remaining
parameters revealed no other significant differencres from
controls.
Effects in organs:
Organ weights:
For female rats in all dose groups unadjusted brain weights
were significantly increased (P<0.05) in comparison with
controls. However, differences were not dosage-dependent and
analysis of adjusted values did not show statistical
significance. Also, all values in the high dose group were
within normal range. These difference were considered not to
be treatment related.
There were no significant differences in organ weights
between control and treated animals. In both sexes there was
a tendency for lower adrenal weights in comparison with
controls in particular in the high dose group.
Differences, however, were not significant and the majority
of individual values fell within the expected range.
Macroscopic pathology:
The macroscopic examination performed at termination
revealed no changes attributable to treatment.
Microscopic pathology:
No treatment-related changes were observed. All
histopathological findings were considered to be of no
toxicological importance.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Classified as: Not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.